[Skip to Content]
[Skip to Content Landing]
Article
August 1992

Treatment With Intravitreal Steroid Reduces Blood-Retinal Barrier Breakdown due to Retinal Photocoagulation

Author Affiliations

From the Department of Ophthalmology, Duke University Medical Center, Durham, NC (Drs Wilson, Sato, Ando, Handa, and de Juan), and National Institutes of Environmental Health Sciences, Research Triangle Park, NC (Dr Berkowitz). Dr Sato is on leave from the Department of Ophthalmology, Nihon University, Tokyo, Japan; Dr Ando is on leave from the Department of Ophthalmology, Niigata (Japan) University; and Drs Wilson and Berkowitz are now with the Department of Ophthalmology, Southwestern Medical School, Dallas, Tex.

Arch Ophthalmol. 1992;110(8):1155-1159. doi:10.1001/archopht.1992.01080200135041
Abstract

• The effect of corticosteroid treatment on blood-retinal barrier breakdown caused by argon-laser panretinal photocoagulation was evaluated in the rabbit eye. One day before photocoagulation, eyes were given either a sub-Tenon (20-mg) or intravitreal (2-mg) injection of triamcinolone acetonide. The severity of blood-retinal barrier breakdown was measured after photocoagulation using rapid sequential magnetic resonance imaging follow-ing intravenous administration of gadolinium diethylenetriaminepentaacetic acid. Leakage of gadolinium diethylenetriaminepentaacetic acid into the vitreous space was significantly lower in eyes that received intravitreal triamcinolone acetonide than in control eyes (P=.007); however, sub-Tenon triamcinolone acetonide produced no significant reduction in leak-age (P=.65) compared with controls. Fluorescein angiography supported the magnetic resonance imaging findings. We conclude that retinal photocoagulation in the rabbit eye produces blood-retinal barrier breakdown that is partially amenable to corticosteroid treatment.

References
1.
Frank RN.  Vascular disease of the retina . In: Tso MOM, ed. Retinal Diseases: Biomedical Foundations and Clinical Management . Philadelphia, Pa: JB Lippincott; 1988:138-164.
2.
Stahl JH, Miller DB, Conway BP, Campochiaro PA.  Dexamethasone and indomethacin attenuate cryopexy induced breakdown of the blood-retinal barrier . Graefes Arch Clin Exp Ophthalmol . 1987;225:418-420.Article
3.
Jaccoma EH, Conway BP, Campochiaro PA.  Cryotherapy causes extensive breakdown of the blood-retinal barrier: a comparison with argon laser photocoagulation . Arch Ophthalmol . 1985;103:1728-1730.Article
4.
Campochiaro PA, Gaskin HC, Vinores SA.  Retinal cryopexy stimulates traction retinal detachment in the presence of an ocular wound . Arch Ophthalmol . 1987;105:1567-1570.Article
5.
Algvere PV, Hallnäs K, Dafgård E, Höög A.  Panretinal photocoagulation aggravates experimental proliferative vitreoretinopathy . Graefes Arch Clin Exp Ophthalmol . 1990;228:461-466.Article
6.
Campochiaro PA, Jerdan BM.  Serum contains chemoattractants for human retinal pigment epithelial cells . Arch Ophthalmol . 1984;102:1830-1833.Article
7.
Campochiaro PA, Glaser BM.  Plateletderived growth factor is chemotactic for human retinal pigment epithelial cells . Arch Ophthalmol . 1985;103:576-579.Article
8.
Campochiaro PA, Bryan JA III, Conway BP, Jaccoma EH.  Intravitreal chemotactic and mitogenic activity: implication of blood-retinal barrier breakdown . Arch Ophthalmol . 1986;104:1685-1687.Article
9.
de Juan E, Dickson JS, Hjelmeland L.  Serum is chemotactic for retinal-derived glial cells . Arch Ophthalmol . 1988;106:986-990.Article
10.
Fandino-Fernandez JM, Fernandez-Vigo J, Sandez J, Carracedo A.  Rupture de la barrière hémato-rétino-vitréenne après photocoagulation . Ophtalmologie . 1989;3:237-238.
11.
Naveh N, Weissman C.  Corticosteroid treatment of laser retinal damage affects prostaglandin E2 response . Invest Ophthalmol Vis Sci . 1990;31:9-13.
12.
Curtin VT, Fujino T, Norton EWD.  Comparative histopathology of cryosurgery and photocoagulation . Arch Ophthalmol . 1966;75:674-682.Article
13.
Berkowitz BA, Sato Y, Wilson CA, de Juan, Jr. E.  Blood-retinal barrier breakdown investigated by real-time MRI following Gd-DTPA injection . Invest Ophthalmol Vis Sci . 1991;32:2854-2860.
14.
Wyatt JD, Scott RAW, Richardson ME.  The effects of prolonged ketamine-xylazine intravenous infusion on arterial blood pH, blood gases, mean arterial blood pressure, heart and respiratory rates, rectal temperature and reflexes in the rabbit . Lab Anim Sci . 1989;39:411-416.
15.
Tso MOM, Wallow IHL, Elgin S.  Experimental photocoagulation of the human retina, I: correlation of physical, clinical and pathologic data . Arch Ophthalmol . 1977;95:1035-1040.Article
16.
Noth JM, Vygantas C, Cunha-Vaz JGF.  Vitreous fluorophotometry evaluation of xenon photocoagulation . Invest Ophthalmol Vis Sci . 1978;17:1206-1209.
17.
Huamonte FU, Peyman GA, Goldberg MF, Locketz A.  Immediate fundus complications after retinal scatter photocoagulation, I: clinical picture and pathogenesis . Ophthalmic Surg . 1976;7:88-99.
18.
Zweng EC, Little HL, Hammond AM.  Complications of argon laser photocoagulation . Trans Am Acad Ophthalmol Otolaryngol . 1974;78:195-204.
19.
Sen HA, Robertson TJ, Conway BP, Campochiaro PA.  The role of breakdown of the blood-retinal barrier in cell-injection models of proliferative vitreoretinopathy . Arch Ophthalmol . 1988;106:1291-1294.Article
20.
Yeo JH, Sadeghi J, Campochiaro PA, Green WR, Glaser BM.  Intravitreous fibronectin and platelet-derived growth factor: new model for traction retinal detachment . Arch Ophthalmol . 1986;104:417-421.Article
21.
Hui Y-N, Goodnight R, Sorgente N, Ryan SJ.  Fibrovascular proliferation and retinal detachment after intravitreal injection of activated macrophages in the rabbit eye . Am J Ophthalmol . 1989;108:176-184.
22.
Jennings T, Rusin MM, Tessler HH, Cunha-Vaz JG.  Posterior sub-Tenon's injections of corticosteroids in uveitis patients with cystoid macular edema . Jpn J Ophthalmol . 1988;32:385-391.
23.
Lewis GD, Campbell WB, Johnson AR.  Inhibition of prostaglandin synthesis by glucocorticoids in human endothelial cells . Endocrinology . 1986;119:62-69.Article
24.
Chandler DB, Hida T, Sheta S, Proia AD, Machemer R.  Improvement in efficacy of corticosteroid therapy in an animal model of proliferative vitreoretinopathy by pretreatment . Graefes Arch Clin Exp Ophthalmol . 1987;225:259-265.Article
25.
Ruhmann AG, Berliner DL.  Effect of steroids on the growth of mouse fibroblasts in vitro . Endocrinology . 1965;76:916-927.Article
26.
Heffernan JT, Futterman S, Kalina RE.  Dexamethasone inhibition of experimental endothelial cell proliferation in retinal venules . Invest Ophthalmol Vis Sci . 1978;17:565-568.
27.
Cariou R, Harousseau JL, Tobelem G.  Inhibition of human endothelial cell proliferation by heparin and steroids . Cell Biol Int Rep . 1988;12:1037-1047.Article
28.
Balow JE, Rosenthal AS.  Glucocorticoid suppression of macrophage migration inhibitory factor . J Exp Med . 1973;137:1031-1039.Article
29.
Shezen E, Shirman M, Goldman R.  Opposing effects of dexamethasone on the clonal growth of granulocyte and macrophage progenitor cells and on the phagocytic capability of mononuclear phagocytes at different stages of differentiation . J Cell Physiol . 1985;124:545-553.Article
30.
Bhattacherjee P, Williams RN, Eakins KE.  A comparison of the ocular antiinflammatory activity of steroidal and nonsteroid compounds in the rat . Invest Ophthalmol Vis Sci . 1983;24:1143-1146.
31.
Weissman G, Thomas L.  Studies on lysosomes, the effect of endotoxin tolerance and cortisone on the release of acid hydrolase from a granular fraction of rabbit liver . J Exp Med . 1962;116:433-450.Article
32.
Bray MA, Gordon D.  Prostaglandin production by macrophages and the effect of antiprostaglandin drugs . Br J Pharmacol . 1978;63:635-642.Article
33.
Heidenreich S, Gong JH, Schmidt A, Nain M, Gemsa D.  Macrophage activation by granulocyte/macrophage colony-stimulating factor: priming for enhanced release of tumor necrosis factor-alpha and prostaglandin E2 . J Immunol . 1989;143:1198-1205.
34.
Twining S, Potts D, Burke J.  Acid proteases of vitreal macrophages . Curr Eye Res . 1984;3:1055-1062.Article
35.
Lowry OH, Roberts NR, Schulz DW, Clow JE, Clark JR.  Quantitative histochemistry of retina, II: enzymes of glucose metabolism . J Biol Chem . 1961;236:2813-2820.
36.
Kuwabara T.  Species differences in the retinal pigment epithelium . In: Zinn KM, Marmor MF, eds. The Retinal Pigment Epithelium . Cambridge, Mass: Harvard University Press; 1979:62-63.
37.
Bito LZ.  Species differences in the responses of the eye to irritation and trauma: a hypothesis of divergence in ocular defense mechanisms, and the choice of experimental animals for eye research . Exp Eye Res . 1984;39:807-829.Article
×